Platelet-expressed immune checkpoint regulator GITRL in breast cancer

Owing to their key role in several diseases including cancer, activating and inhibitory immune checkpoint molecules are increasingly exploited as targets for immunotherapy. Recently, we demonstrated that platelets, which largely influence tumor progression and immune evasion, functionally express th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanjun, Heitmann, Jonas S., Clar, Kim L., Kropp, Korbinian N., Hinterleitner, Martina, Engler, Tobias, Koch, André, Hartkopf, Andreas D., Zender, Lars, Salih, Helmut R., Maurer, Stefanie, Hinterleitner, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360840/
https://www.ncbi.nlm.nih.gov/pubmed/33538861
http://dx.doi.org/10.1007/s00262-021-02866-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360840/
https://www.ncbi.nlm.nih.gov/pubmed/33538861
http://dx.doi.org/10.1007/s00262-021-02866-y

Ejemplares similares